387 related articles for article (PubMed ID: 25649351)
1. SOCS3 Deficiency in Myeloid Cells Promotes Tumor Development: Involvement of STAT3 Activation and Myeloid-Derived Suppressor Cells.
Yu H; Liu Y; McFarland BC; Deshane JS; Hurst DR; Ponnazhagan S; Benveniste EN; Qin H
Cancer Immunol Res; 2015 Jul; 3(7):727-40. PubMed ID: 25649351
[TBL] [Abstract][Full Text] [Related]
2. CCR5 Blockade Suppresses Melanoma Development Through Inhibition of IL-6-Stat3 Pathway via Upregulation of SOCS3.
Tang Q; Jiang J; Liu J
Inflammation; 2015 Dec; 38(6):2049-56. PubMed ID: 26047948
[TBL] [Abstract][Full Text] [Related]
3. Signal transducer and activator of transcription-3/suppressor of cytokine signaling-3 (STAT3/SOCS3) axis in myeloid cells regulates neuroinflammation.
Qin H; Yeh WI; De Sarno P; Holdbrooks AT; Liu Y; Muldowney MT; Reynolds SL; Yanagisawa LL; Fox TH; Park K; Harrington LE; Raman C; Benveniste EN
Proc Natl Acad Sci U S A; 2012 Mar; 109(13):5004-9. PubMed ID: 22411837
[TBL] [Abstract][Full Text] [Related]
4. Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events.
Schouppe E; Mommer C; Movahedi K; Laoui D; Morias Y; Gysemans C; Luyckx A; De Baetselier P; Van Ginderachter JA
Eur J Immunol; 2013 Nov; 43(11):2930-42. PubMed ID: 23878002
[TBL] [Abstract][Full Text] [Related]
5. Tumor-associated GM-CSF overexpression induces immunoinhibitory molecules via STAT3 in myeloid-suppressor cells infiltrating liver metastases.
Thorn M; Guha P; Cunetta M; Espat NJ; Miller G; Junghans RP; Katz SC
Cancer Gene Ther; 2016 Jun; 23(6):188-98. PubMed ID: 27199222
[TBL] [Abstract][Full Text] [Related]
6. Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function.
Nam S; Kang K; Cha JS; Kim JW; Lee HG; Kim Y; Yang Y; Lee MS; Lim JS
J Leukoc Biol; 2016 Dec; 100(6):1273-1284. PubMed ID: 27601624
[TBL] [Abstract][Full Text] [Related]
7. Distinct activities of suppressor of cytokine signaling (SOCS) proteins and involvement of the SOCS box in controlling G-CSF signaling.
van de Geijn GJ; Gits J; Touw IP
J Leukoc Biol; 2004 Jul; 76(1):237-44. PubMed ID: 15107455
[TBL] [Abstract][Full Text] [Related]
8. SOCS3 and STAT3, major controllers of the outcome of infection with Mycobacterium tuberculosis.
Rottenberg ME; Carow B
Semin Immunol; 2014 Dec; 26(6):518-32. PubMed ID: 25458989
[TBL] [Abstract][Full Text] [Related]
9. SOCS3 Suppression Promoted the Recruitment of CD11b
Zhang W; Jiang M; Chen J; Zhang R; Ye Y; Liu P; Yu W; Yu J
Front Immunol; 2018; 9():1699. PubMed ID: 30083161
[TBL] [Abstract][Full Text] [Related]
10. Serum amyloid A3 exacerbates cancer by enhancing the suppressive capacity of myeloid-derived suppressor cells via TLR2-dependent STAT3 activation.
Lee JM; Kim EK; Seo H; Jeon I; Chae MJ; Park YJ; Song B; Kim YS; Kim YJ; Ko HJ; Kang CY
Eur J Immunol; 2014 Jun; 44(6):1672-84. PubMed ID: 24659444
[TBL] [Abstract][Full Text] [Related]
11. SOCS3 promoter methylation is mutually exclusive to EGFR amplification in gliomas and promotes glioma cell invasion through STAT3 and FAK activation.
Lindemann C; Hackmann O; Delic S; Schmidt N; Reifenberger G; Riemenschneider MJ
Acta Neuropathol; 2011 Aug; 122(2):241-51. PubMed ID: 21590492
[TBL] [Abstract][Full Text] [Related]
12. Myeloid-derived suppressor cell functionality and interaction with Leishmania major parasites differ in C57BL/6 and BALB/c mice.
Schmid M; Zimara N; Wege AK; Ritter U
Eur J Immunol; 2014 Nov; 44(11):3295-306. PubMed ID: 25142017
[TBL] [Abstract][Full Text] [Related]
13. Critical and independent role for SOCS3 in either myeloid or T cells in resistance to Mycobacterium tuberculosis.
Carow B; Reuschl AK; Gavier-Widén D; Jenkins BJ; Ernst M; Yoshimura A; Chambers BJ; Rottenberg ME
PLoS Pathog; 2013; 9(7):e1003442. PubMed ID: 23853585
[TBL] [Abstract][Full Text] [Related]
14. STAT3 Silencing and TLR7/8 Pathway Activation Repolarize and Suppress Myeloid-Derived Suppressor Cells From Breast Cancer Patients.
Safarzadeh E; Mohammadi A; Mansoori B; Duijf PHG; Hashemzadeh S; Khaze V; Kazemi T; Derakhshani A; Silvestris N; Baradaran B
Front Immunol; 2020; 11():613215. PubMed ID: 33679700
[TBL] [Abstract][Full Text] [Related]
15. Loss of SOCS3 in myeloid cells prolongs survival in a syngeneic model of glioma.
McFarland BC; Marks MP; Rowse AL; Fehling SC; Gerigk M; Qin H; Benveniste EN
Oncotarget; 2016 Apr; 7(15):20621-35. PubMed ID: 26967393
[TBL] [Abstract][Full Text] [Related]
16. Polyunsaturated fatty acids promote the expansion of myeloid-derived suppressor cells by activating the JAK/STAT3 pathway.
Yan D; Yang Q; Shi M; Zhong L; Wu C; Meng T; Yin H; Zhou J
Eur J Immunol; 2013 Nov; 43(11):2943-55. PubMed ID: 23897117
[TBL] [Abstract][Full Text] [Related]
17. Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells.
Deng Y; Cheng J; Fu B; Liu W; Chen G; Zhang Q; Yang Y
Oncogene; 2017 Feb; 36(8):1090-1101. PubMed ID: 27593937
[TBL] [Abstract][Full Text] [Related]
18. Polysaccharide Agaricus blazei Murill stimulates myeloid derived suppressor cell differentiation from M2 to M1 type, which mediates inhibition of tumour immune-evasion via the Toll-like receptor 2 pathway.
Liu Y; Zhang L; Zhu X; Wang Y; Liu W; Gong W
Immunology; 2015 Nov; 146(3):379-91. PubMed ID: 26194418
[TBL] [Abstract][Full Text] [Related]
19. Targeted STAT3 disruption in myeloid cells alters immunosuppressor cell abundance in a murine model of spontaneous medulloblastoma.
Abad C; Nobuta H; Li J; Kasai A; Yong WH; Waschek JA
J Leukoc Biol; 2014 Feb; 95(2):357-67. PubMed ID: 24068730
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of SOCS3 in T lymphocytes leads to impaired interleukin-17 production and severe aortic aneurysm formation in mice--brief report.
Romain M; Taleb S; Dalloz M; Ponnuswamy P; Esposito B; Pérez N; Wang Y; Yoshimura A; Tedgui A; Mallat Z
Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):581-4. PubMed ID: 23329138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
